PHARMOS, a.s.

Profit Statement 2015 2016 2017
Sales CZK mil 10,628 11,306 10,899
Gross Profit CZK mil 204 250 208
EBITDA CZK mil 51.8 94.9 53.9
EBIT CZK mil 31.0 72.2 35.2
Financing Cost CZK mil 6.37 16.9 9.79
Pre-Tax Profit CZK mil 24.6 55.4 25.4
Net Profit CZK mil 13.6 44.3 20.3
Dividends CZK mil 0 20.1 ...
Balance Sheet 2015 2016 2017
Total Assets CZK mil 3,459 3,713 3,440
Non-Current Assets CZK mil 218 203 219
Current Assets CZK mil 3,236 3,500 3,215
Working Capital CZK mil 1,114 1,741 1,702
Shareholders' Equity CZK mil 594 639 640
Liabilities CZK mil 2,865 3,074 2,800
Total Debt CZK mil 1,417 1,445 1,385
Net Debt CZK mil 1,333 1,367 1,352
Ratios 2015 2016 2017
ROE % 2.33 7.19 3.17
ROCE % 0.974 2.71 1.05
Gross Margin % 1.92 2.21 1.91
EBITDA Margin % 0.488 0.840 0.494
EBIT Margin % 0.291 0.639 0.323
Net Margin % 0.128 0.392 0.186
Net Debt/EBITDA 25.7 14.4 25.1
Net Debt/Equity % 224 214 211
Cost of Financing % 0.449 1.18 0.691
Cash Flow 2015 2016 2017
Total Cash From Operations CZK mil 125 -25.5 68.2
Total Cash From Investing CZK mil -27.4 -9.11 -33.3
Total Cash From Financing CZK mil -36.3 28.8 -20.1
Net Change In Cash CZK mil 61.0 -5.84 14.8
Cash Conversion Cycle days 38.1 55.9 56.9
Cash Earnings CZK mil 34.5 67.0 38.9
Free Cash Flow CZK mil 97.2 -34.6 34.9

Get all company financials in excel:

Download Sample   $19.99

summary Unit 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
income statement                        
Sales CZK mil           14,215 14,001 10,989 10,702 10,628    
Gross Profit CZK mil           283 273 209 202 204    
EBIT CZK mil           67.8 10.2 15.3 23.1 31.0    
Net Profit CZK mil           16.2 -27.0 6.41 5.89 13.6    
ROE %           2.71 -4.58 1.12 1.02 2.33    
EBIT Margin %           0.477 0.073 0.139 0.215 0.291    
Net Margin %           0.114 -0.193 0.058 0.055 0.128    
Employees ...         617 592 466 438 437    
balance sheet                        
Total Assets CZK mil           4,653 4,324 4,043 3,626 3,459    
Non-Current Assets CZK mil           234 225 219 208 218    
Current Assets CZK mil           4,378 4,059 3,801 3,413 3,236    
Shareholders' Equity CZK mil           604 573 576 579 594    
Liabilities CZK mil           4,049 3,751 3,467 3,047 2,865    
Non-Current Liabilities CZK mil           11.1 9.42 4.96 1.73 5.98    
Current Liabilities CZK mil           2,158 1,974 1,896 1,579 1,420    
Net Debt/EBITDA ...         19.0 43.5 38.2 30.9 25.7    
Net Debt/Equity % ...         291 266 263 241 224    
Cost of Financing % ... ...       2.67 1.93 0.626 1.04 0.449    
cash flow                        
Total Cash From Operations CZK mil           -117 136 -147 126 125    
Total Cash From Investing CZK mil           -4.35 -15.5 -22.7 -10.4 -27.4    
Total Cash From Financing CZK mil           -3.30 -4.49 -1.91 -110 -36.3    
Net Change In Cash CZK mil           -125 116 -172 5.88 61.0    
income statement Unit 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
income statement                        
Sales CZK mil           14,215 14,001 10,989 10,702 10,628    
Cost of Goods & Services CZK mil           13,933 13,729 10,780 10,500 10,424    
Gross Profit CZK mil           283 273 209 202 204    
Staff Cost CZK mil           169 168 132 124 125    
Other Cost CZK mil           21.4 69.8 37.8 32.8 26.8    
EBITDA CZK mil           92.5 35.1 39.6 45.3 51.8    
Depreciation CZK mil           24.8 24.9 24.3 22.2 20.9    
EBIT CZK mil           67.8 10.2 15.3 23.1 31.0    
Financing Cost CZK mil           47.2 34.2 10.2 15.4 6.37    
Extraordinary Cost CZK mil           0 0 0 0 0    
Pre-Tax Profit CZK mil           20.6 -24.0 5.12 7.67 24.6    
Tax CZK mil           4.37 3.00 -1.29 1.78 10.9    
Minorities CZK mil           0 0 0 0 0    
Net Profit CZK mil           16.2 -27.0 6.41 5.89 13.6    
Dividends CZK mil           4.33 1.80 1.99 31.1 0   ...
growth rates                        
Total Revenue Growth % ...         0.685 -1.51 -21.5 -2.61 -0.696    
Operating Cost Growth % ...         -0.988 24.8 -28.5 -7.70 -2.91    
EBITDA Growth % ...         -11.3 -62.0 12.7 14.4 14.5    
EBIT Growth % ...         -15.8 -85.0 49.9 50.9 34.2    
Pre-Tax Profit Growth % ...         4.00 -216 -121 49.8 221    
Net Profit Growth % ...         12.1 -266 -124 -8.23 132    
ratios                        
ROE %           2.71 -4.58 1.12 1.02 2.33    
ROCE % ... ...       0.928 -1.54 0.396 0.378 0.974    
Gross Margin %           1.99 1.95 1.90 1.89 1.92    
EBITDA Margin %           0.651 0.251 0.360 0.423 0.488    
EBIT Margin %           0.477 0.073 0.139 0.215 0.291    
Net Margin %           0.114 -0.193 0.058 0.055 0.128    
Payout Ratio %           26.7 -6.67 31.0 528 0   ...
Cost of Financing % ... ...       2.67 1.93 0.626 1.04 0.449    
Net Debt/EBITDA ...         19.0 43.5 38.2 30.9 25.7    
balance sheet Unit 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
balance sheet                        
Non-Current Assets CZK mil           234 225 219 208 218    
Property, Plant & Equipment CZK mil           228 211 191 174 180    
Intangible Assets CZK mil           3.81 11.1 16.0 22.1 21.1    
Current Assets CZK mil           4,378 4,059 3,801 3,413 3,236    
Inventories CZK mil           1,303 1,208 1,288 1,199 1,131    
Receivables CZK mil ...         2,461 2,076 1,942 1,561 1,336    
Cash & Cash Equivalents CZK mil           73.4 189 17.3 23.2 84.2    
Total Assets CZK mil           4,653 4,324 4,043 3,626 3,459    
Shareholders' Equity CZK mil           604 573 576 579 594    
Of Which Minority Interest CZK mil           0 0 0 0 0    
Liabilities CZK mil           4,049 3,751 3,467 3,047 2,865    
Non-Current Liabilities CZK mil           11.1 9.42 4.96 1.73 5.98    
Long-Term Debt CZK mil ...         0.271 0.113 0 0 0    
Deferred Tax Liabilities CZK mil ...         10.9 9.31 4.96 1.73 5.98    
Current Liabilities CZK mil           2,158 1,974 1,896 1,579 1,420    
Short-Term Debt CZK mil ...         1,830 1,716 1,530 1,422 1,417    
Trade Payables CZK mil ...         2,080 1,913 1,806 1,497 1,353    
Provisions CZK mil           0.169 0.105 0 0.080 2.28    
Equity And Liabilities CZK mil           4,653 4,324 4,043 3,626 3,459    
growth rates                        
Total Asset Growth % ...         13.9 -7.07 -6.50 -10.3 -4.63    
Shareholders' Equity Growth % ...         2.21 -5.18 0.515 0.550 2.57    
Net Debt Growth % ... ...       16.9 -13.1 -0.908 -7.52 -4.73    
Total Debt Growth % ... ...       7.64 -6.26 -10.8 -7.05 -0.364    
ratios                        
Total Debt CZK mil ...         1,830 1,716 1,530 1,422 1,417    
Net Debt CZK mil ...         1,757 1,526 1,512 1,399 1,333    
Working Capital CZK mil ...         1,685 1,371 1,424 1,263 1,114    
Capital Employed CZK mil ...         1,919 1,596 1,643 1,471 1,332    
Net Debt/Equity % ...         291 266 263 241 224    
Cost of Financing % ... ...       2.67 1.93 0.626 1.04 0.449    
cash flow Unit 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
cash flow                        
Net Profit CZK mil           16.2 -27.0 6.41 5.89 13.6    
Depreciation CZK mil           24.8 24.9 24.3 22.2 20.9    
Non-Cash Items CZK mil ... ...       206 -176 -125 -63.0 -58.6    
Change in Working Capital CZK mil ... ...       -365 314 -52.8 161 149    
Total Cash From Operations CZK mil           -117 136 -147 126 125    
Capital Expenditures CZK mil           -6.26 -17.6 -23.9 -12.1 -27.5    
Other Investments CZK mil           1.91 2.10 1.16 1.75 0.139    
Total Cash From Investing CZK mil           -4.35 -15.5 -22.7 -10.4 -27.4    
Dividends Paid CZK mil ...         -3.15 -4.33 -1.80 -1.99 -31.1    
Issuance Of Shares CZK mil           0 0 0 0 0    
Issuance Of Debt CZK mil ... ...       130 -115 -186 -108 -5.18    
Total Cash From Financing CZK mil           -3.30 -4.49 -1.91 -110 -36.3    
Net Change In Cash CZK mil           -125 116 -172 5.88 61.0    
ratios                        
Days Sales Outstanding days ...         63.2 54.1 64.5 53.2 45.9    
Days Sales Of Inventory days           34.1 32.1 43.6 41.7 39.6    
Days Payable Outstanding days ...         54.5 50.9 61.2 52.0 47.4    
Cash Conversion Cycle days ...         42.8 35.4 47.0 42.9 38.1    
Cash Earnings CZK mil           41.0 -2.05 30.7 28.1 34.5    
Free Cash Flow CZK mil           -121 120 -170 116 97.2    
other data Unit 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
other data                        
ROA %           0.371 -0.601 0.153 0.153 0.385    
Gross Margin %           1.99 1.95 1.90 1.89 1.92    
Employees ...         617 592 466 438 437    
Cost Per Employee USD per month ...         1,290 1,207 1,206 1,103 1,001    
Cost Per Employee (Local Currency) CZK per month ...         22,817 23,611 23,591 23,569 23,899    
Staff Cost (As % Of Total Cost) %           1.19 1.20 1.20 1.16 1.18    
Effective Tax Rate %           21.2 -12.5 -25.3 23.2 44.5    
Domestic Sales CZK mil ... ... ...     14,211 13,955 10,978 10,655 10,612 ... ...
Capital Expenditures (As % of Sales) %           0.044 0.126 0.217 0.113 0.259    
Revenues From Abroad CZK mil ... ... ...     64.5 68.6 44.8 79.3 48.5 ... ...
Revenues From Abroad (As % Of Total) % ... ... ...     0.454 0.490 0.407 0.741 0.457 ... ...

Get all company financials in excel:

Download Sample   $19.99

PHARMOS, a.s. is a Czech Republic-based distributor of medications and pharmaceuticals to public and hospital pharmacies in Czech Republic. The company was founded in 1991 and is based in Ostrava, Czech Republic. PHARMOS, a.s. operates as a subsidiary of Ceska Lekarnicka.